Galapagos has signed a deal to jettison its troubled JAK inhibitor drug Jyseleca, agreeing to sell the rights to rheumatoid arthritis and ulcerative colitis therapy to Italy’s Alfasigma SpA in a deal ...

The FDA has approved Incyte's Opzelura cream for atopic dermatitis, commonly called eczema, becoming the first and only topical JAK inhibitor registered in the US. Opzelura (ruxolitinib) – which has ...

CPM Engineering owner Jason McPherson spent five years developing the Ali-Jak, and he is thrilled to see it head to a Chinchilla mine to make its debut on what was already an important day. "It's my ...

Become a member of The Crime Desk for exclusive bonus episodes of The Trial EVERY WEEK Get access to over 200 episodes from the original Lucy Letby trial to Holly Willoughby and our acclaimed Trial of ...

EXCLUSIVEInside the brutal, gory world of bare knuckle boxing and its troubling rise: The primal reasons that fighters risk everything to get out of a 'safe zone', why Gen Z are flocking to it and the ...